Login / Signup

Should we consider progression-free survival benefits enough for drug approvals in locally advanced cervical cancer?

Alexandre Andre B A da CostaRonaldo Pereira SouzaNatasha Carvalho PandolfiFabrício de Souza CastroGlauco BaiocchiAndrea Paiva G Guimarães
Published in: Gynecologic oncology (2024)
Keyphrases
  • free survival
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • emergency department
  • drug induced
  • study protocol